Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Biomarkers for Evaluation of Hemostasis and Inflammation in Liver Cirrhosis

NCT06212635 is registered in ClinicalTrials.gov with Region Stockholm as lead sponsor.

NCT NCT06212635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06212635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Biomarkers for Evaluation of Hemostasis and Inflammation in Liver Cirrhosis
Lead sponsor
Region Stockholm
Phase
Observational
Overall status
Recruiting
Start date
December 2, 2022
Completion date
December 1, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemostasis in decompensated liver cirrhosis, inflammation in decompensated liver cirrhosis